From 557a87fd1451b24e5361c21fc782f8732f1f7874 Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Mon, 19 Feb 2024 14:58:57 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/Kenia.md | 3 +++ pages/STOP2030___Web.md | 6 ++++-- 2 files changed, 7 insertions(+), 2 deletions(-) create mode 100644 pages/Kenia.md diff --git a/pages/Kenia.md b/pages/Kenia.md new file mode 100644 index 00000000..0311475a --- /dev/null +++ b/pages/Kenia.md @@ -0,0 +1,3 @@ +alias:: Kenya + +- \ No newline at end of file diff --git a/pages/STOP2030___Web.md b/pages/STOP2030___Web.md index 3e556b96..4031517b 100644 --- a/pages/STOP2030___Web.md +++ b/pages/STOP2030___Web.md @@ -15,7 +15,7 @@ - Pilot antihelmintic resistance surveillance based on genetic epidemiology - Investigadores principales de cada uno de los partners - Timeline y milestones (cuáles se han cumplido?) - - Proposed safety and effectiveness study + - __Proposed safety and effectiveness study__ - *Primary objective*: To evaluate and compare safety of a [[FDC]] against [[Albendazole]] alone via [[MDA]] in two study areas in Kenya and [[Ghana]]. - *Secondary objectives*: - To evaluate the effectiveness of one round of [[MDA]] with [[FDC]] vs [[Albendazole]] against [[STH]] (T. trichiura, A. lumbricoides, hookworms) [[by]] microscopy @@ -25,6 +25,8 @@ - *Sample size*: approx. 20k. - *Target population*: School based - *Epidemiologic conditions of the sites*: T. trichiura ongoing transmission areas - - *Countries*: + - *Countries*: [[Ghana]] and [[Kenya]] + - + - - - \ No newline at end of file